Kobiolabs

Developing microbiome therapeutics, companion diagnostics, and medicinal foods

placeSeoul, Seoul, South Korea calendar_todayFounded 2014 groups53 employees language kobiolabs.com

Innovation

32 patent families (11 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 743 times.

YearFilings
20161
20182
20195
202010
20219
202210
202312
202410
20258
20263

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital450%
Private equity225%
Other / undisclosed225%
Coming soon